Anti-ERK1 + ERK2 antibody [ERK-7D8] (Ab54230)
ERK1, PRKM3, MAPK3, Mitogen-activated protein kinase 3, MAP kinase 3, MAPK 3, ERT2, Extracellular signal-regulated kinase 1, Insulin-stimulated MAP2 kinase, MAP kinase isoform p44, Microtubule-associated protein 2 kinase, p44-ERK1, ERK-1, p44-MAPK, ERK2, PRKM1, PRKM2, MAPK1, Mitogen-activated protein kinase 1, MAP kinase 1, MAPK 1, ERT1, Extracellular signal-regulated kinase 2, MAP kinase isoform p42, Mitogen-activated protein kinase 2, ERK-2, p42-MAPK, MAP kinase 2, MAPK 2
详细信息
文献引用 (92)
Memantine abrogates testicular dysfunction induced by risperidone in rats with a potential role of ERK1/2-Nrf2-caspase-3 signaling pathway.
美金刚可消除利培酮引起的大鼠睾丸功能障碍,这可能与 ERK1/2-Nrf2-caspase-3 信号通路有关
Circular RNA hsa_circ_103089 modulates metabolic glycolysis and influences migration, invasion, and cisplatin sensitivity in non-small cell lung cancer cells via the miR-876-5p/EGFR axis
环状RNA hsa_circ_103089通过miR-876-5p/EGFR轴调节非小细胞肺癌细胞的代谢糖酵解,并影响其迁移、侵袭和顺铂敏感性。
ERK builds a population of short-lived nascent adhesions that produce persistent edge protrusion and cell migration.
ERK 会形成一群短暂存在的新生粘附物,从而产生持续的边缘突出和细胞迁移。
Differential contribution for ERK1 and ERK2 kinases in BRAFV600E-triggered phenotypes in adult mouse models
成年小鼠模型中 BRAFV600E 引发的表型中 ERK1 和 ERK2 激酶的差异贡献
Evaluation of the Expression EGFR, HER2/NEU and the End Effector ERK of the RAS/RAF/MAP Kinase Pathway in Prostatic Adenocarcinoma for a Possible Role as New Target Therapy
评估前列腺腺癌中 EGFR、HER2/NEU 和 RAS/RAF/MAP 激酶通路末端效应子 ERK 的表达作为新靶向治疗的可能作用
Live Cell Lineage Tracing of Dormant Cancer Cells
休眠癌细胞的活细胞谱系追踪
Microbiota dysbiosis influences immune system and muscle pathophysiology of dystrophin-deficient mice
微生物群失调影响肌营养不良蛋白缺乏小鼠的免疫系统和肌肉病理生理
Targeting the up-regulated CNOT3 reverses therapeutic resistance and metastatic progression of EGFR-mutant non-small cell lung cancer
靶向上调的 CNOT3 可逆转 EGFR 突变型非小细胞肺癌的治疗耐药性和转移进展
miR-126 mitigates the osteogenic differentiation of human bone marrow-derived mesenchymal stem cells by targeting the ERK1/2 and Bcl-2 pathways
miR-126 通过靶向 ERK1/2 和 Bcl-2 通路减缓人类骨髓间充质干细胞的成骨分化
- 1
- 2
- 3
- 4
- 5
- 6
- 10